510(k) Report

510(k) · Cleared

Cleared

BD AutoShield Duo™ Pen Needle

K223286510(k) TraditionalCleared Dec 28, 202264-day reviewClass II21 CFR 880.5570

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Becton, Dickinson and Company · FMI Needle, Hypodermic, Single Lumen

Cleared on Dec 28, 2022 as substantially equivalent to K110703 (Becton, Dickinson and Company, 2011) after a 64-day review. Its family tree reaches back 3 generations to 2005. 1 later device descends from it.

Decided
Dec 28, 2022
Review
64 days
Class
Class II
Product code
FMI
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K051899 (2005). 1 later device descends from it, 1 citing it directly.

  1. Root · 3 generations backK051899 BD Pen NeedleBecton, Dickinson & CO · 2005
  2. 2 generations backK060007 BD Autoshield Pen NeedleBecton, Dickinson & CO · 2006 · Recalled
  3. 1 generation backK110703 BD Autoshield Duo Pen NeedleBecton, Dickinson and Company · 2011
  4. This deviceK223286 BD AutoShield Duo™ Pen NeedleBecton, Dickinson and Company · 2022
  5. Descendant · cites it directly · 0 of its ownK261266 MOWANA™ Auto DuoPentamaster Mediq SDN BHD · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K261266MOWANA™ Auto DuoPentamaster Mediq SDN BHD · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K051899BD Pen NeedleBecton, Dickinson & CO2005—
−2K060007BD Autoshield Pen NeedleBecton, Dickinson & CO20061
−1K110703BD Autoshield Duo Pen NeedleBecton, Dickinson and Company2011—
0 (this device)K223286BD AutoShield Duo™ Pen NeedleBecton, Dickinson and Company2022—
+1K261266MOWANA™ Auto DuoPentamaster Mediq SDN BHD2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K223286, 2005–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FMI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FMI device

  1. #1 K252886 Pen Needlescore 14.5 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K110703BD Autoshield Duo Pen Needle
Summary page 4
…Product Code: FMI (hypodermic single lumen needle) Legally marketed predicate device to which substantial equivalence is being claimed: K110703: BD AutoShield™ Duo Pen Needle Purpose of Submission: The purpose of this submission is to provide a minor administrative updat…
Becton, Dickinson and Company2011—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K261266MOWANA™ Auto DuoPentamaster Mediq SDN BHD20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 2 companies; a new generation was cleared every 5.3 years on median.
  • 1 of the 3 ancestors has a recall of any class.
  • Of its descendants, K261266 (Pentamaster Mediq SDN BHD, 2026) has gone furthest, with 0 descendants of its own.

How does its category compare?

All FMI devices

FMI Needle, Hypodermic, Single Lumen: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · FMI

11in 2025

2007: 152008: 102009: 72010: 152011: 122012: 172013: 112014: 142015: 102016: 202017: 92018: 202019: 122020: 112021: 182022: 232023: 182024: 32025: 112026 (partial year): 12
2007high 23 (2022) · low 3 (2024)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FMI

141in 2025

2007: 71 days median2008: 85 days median2009: 177 days median2010: 119 days median2011: 113 days median2012: 107 days median2013: 87 days median2014: 155 days median2015: 89 days median2016: 217 days median2017: 253 days median2018: 176 days median2019: 186 days median2020: 263 days median2021: 143 days median2022: 189 days median2023: 112 days median2024: 90 days median2025: 141 days median2026 (partial year): 119 days median
2007high 263 (2020) · low 71 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FMI

1in 2024

2007: 22008: 42009: 32010: 792011: 52012: 12013: 12014: 32015: 12017: 162019: 52020: 32021: 72023: 22024: 12026 (partial year): 1, 1 Class I
2007high 79 (2010) · low 0 (2016)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · FMI

2,424in 2025

2007: 2082008: 1772009: 2632010: 2492011: 2402012: 2152013: 2552014: 2872015: 5672016: 9412017: 1,5472018: 2,3982019: 4,8962020: 4,2452021: 4,5322022: 4,8852023: 4,9862024: 4,0532025: 2,424
2007high 4,986 (2023) · low 177 (2008)2025

MAUDE reports naming product code FMI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200715712208
200810854177
200971773263
20101511979249
2011121135240
2012171071215
201311871255
2014141553287
201510891567
2016202170941
20179253161,547
20182017602,398
20191218654,896
20201126334,245
20211814374,532
20222318904,885
20231811224,986
202439014,053
20251114102,424
2026121191 (1)—

What is it indicated for?

The BD AutoShield Duo™ Pen Needle is intended for use with pen injector devices for the subcutaneous injection of drugs.

The product has two safety shields, which lock in place after use (patient-end) and upon removal of the needle from the pen (pen connection-end). The locked shields help reduce the occurrence of needle sticks from both ends of the needle.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K223286: BD AutoShield Duo™ Pen Needle.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K223286

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026